Bristol-Myers Squibb entered a collaboration with Duke University’s Clinical Research Institute (DCRI) to expand access to certain clinical trial information for independent scientific review through DCRI. This collaboration is one of a series of initiatives by BMS to support data sharing and disclosure of clinical trial information for scientific research and will include protocols, full clinical study reports (CSR) and de-identified patient-level data and study-level data for drugs and indicat...